When you think of Covid-19 vaccines, you probably think of Pfizer, Moderna, and Johnson & Johnson (and likely in that order!). Well, according to a recent New York Times article, there’s a new player in the vaccine game, and it’s from China’s Sinopharm. Last Friday, the World Health Organization approved the vaccine for emergency use, allowing the vaccine to be included in Covax, the W.H.O.’s global program for promoting equitable access to vaccines around the world.
W.H.O. Grants Emergency Use Authorization to Sinopharm’s Covid-19 Vaccine
The approval will likely expand vaccine availability to poorer nations amid the pandemic.
May 11, 2021
Recommended
Recommended
Pharmaceutical Innovations Report
Discover the latest breakthrough packaging technologies shaping the pharmaceutical sector. This report dives into cutting-edge innovations, from smart containers that enhance patient safety to eco-friendly materials poised to transform the industry’s sustainability practices. All from PACK EXPO. Learn how forward-thinking strategies are driving efficiency and redefining what’s possible in pharma packaging.
Learn More
Medical Device Innovations Report
Cutting-edge packaging technologies are transforming the medical device sector in PMMI’s “Innovation in Medical Device” report, featuring advanced materials, smart solutions, and evolving regulations. Editors share insights from nearly 300 PACK EXPO booth visits—each product deemed new and truly innovative—alongside video demonstrations of the equipment and materials on display.
Learn More
